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Abstract: The speed and innovation of the COVID-19 vaccine development has been accompanied 
by insecurity and skepticism. Young adults’ attitude to vaccination remains under investigation, 
although herd immunity cannot be reached without them. The HEalth in Students during the Co-
rona pandemic study (HES-C) provided the opportunity to investigate vaccination intention in 1478 
students in the sixth survey wave (January 2021), including vaccination intention, psychological 
antecedents of vaccine hesitancy, trust in government’s vaccination strategy, and vaccination his-
tory. Associations with vaccination intention were analyzed with multivariate ordinal regression 
and predicted margins were calculated adjusting for gender, age, anxiety, health profession, and 
subjective health status. A third was decided (yes 25.1%, no 7.6%), and 68% were unsure about get-
ting the COVID-19 vaccine when available. Next to demographic characteristics, vaccination history 
(influenza vaccination OR = 1.39; 95% CI: 1.06–1.83, travel vaccination OR = 1.29; 95% CI: 1.04–1.60), 
trust in vaccination strategy (OR = 2.40; 95% CI: 1.89–3.05), and 5C dimensions were associated with 
vaccination intention: confidence (OR = 2.52; 95% CI: 2.09–3.03), complacency (OR = 0.79; 95% CI: 
0.66–0.96), calculation (OR = 0.79; 95% CI: 0.70–0.89), constraints (OR = 1.18; 95% CI: 0.99–1.41), and 
collective responsibility (OR = 4.47; 95% CI: 3.69–5.40). Addressing psychological antecedents and 
strengthening trust in official strategies through targeted campaigns and interventions may increase 
decisiveness and result in higher vaccination rates. 
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1. Introduction 
The SARS-CoV-2 vaccination is as unprecedented as the COVID-19 pandemic itself. 
Never before has a vaccination been developed so quickly after the identification of a vi-
rus. This success was possible due to an international effort and a new methodology, mes-
senger RNA, being applied in the development of the vaccine [1,2]. This quick develop-
ment phase has been coupled with the insecurities and skepticism of the public [3], on one 
hand related to the methodology involving genetic mechanisms and until now non-exist-
ent evidence on long-term effects, and on the other hand to pre-existing vaccine hesitancy. 
Vaccine hesitancy refers to a delay in acceptance or refusal of vaccination, despite the 
availability of vaccination services. It is complex, context specific, and variable across 
time, place, and vaccine [4]. Vaccine hesitancy is present in the majority of WHO member 
states [5]. The top three cited reasons for vaccine hesitancy globally are risk–benefit (sci-
entific evidence), lack of knowledge and awareness of vaccination and its importance, and 
socio-cultural reasons such as religion, culture, gender, and socioeconomic issues regard-
ing vaccines [5].  
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While vaccine hesitancy has been extensively studied in the general adult population, 
and in particular parents, vaccine hesitancy in young adults has been under-investigated 
as this age group was not in the focus of public health vaccine strategy and communica-
tion. However, the current COVID-19 pandemic also brings the younger population into 
the spotlight of vaccine strategies. COVID-19 vaccine hesitancy poses significant risks 
both to people who delay or refuse vaccination and to the wider community. It prevents 
the achievement of the thresholds necessary for herd immunity, unnecessarily perpetuat-
ing the pandemic [6]. First studies indicate that vaccine hesitancy is higher in young adults 
[7]. With respect to university students, they are in particular vulnerable to COVID-19 
infection due to shared housing, the reopening of college campuses and activities, and the 
necessity to travel between their home and campus [8]. Furthermore, college campuses 
have the potential to become “superspreaders”. Such outbreaks tend to spread into the 
neighboring communities, driving the pandemic [9]. Thus, it is critical to address COVID-
19 vaccine hesitancy in students for better controlling COVID-19 spread.  
Only recently, several studies have been published aimed at gaining a deeper under-
standing of COVID-19 vaccine hesitancy and willingness in students. In a study in the 
U.S., almost half (47.5%) of participants reported hesitancy regarding the COVID-19 vac-
cination [8]. Non-hesitant college students in the U.S. showed a higher behavioral confi-
dence (i.e., being sure of properly following through with COVID-19 vaccination despite 
obstacles), participatory dialogue, and changes in the physical environment (i.e., whereby 
the person has necessary resources for performing a given behavior) than students who 
were vaccine hesitant [8]. Sallam et al. [10] investigated COVID-19 vaccine acceptance 
among university students in Jordan and found a low intention to get vaccinated against 
COVID-19 (34.9%). Higher rates were observed among males (42.1%) and students at 
Health Schools (43.5%) as compared to other faculties. A major result of this study was 
the independent correlation between the belief in conspiracy and COVID-19 vaccine hes-
itancy [10].  
Switzerland introduced containment measures including closure of schools and uni-
versities mid-March 2020 (17.03.2020) with the beginning of the first wave. As in most 
European countries, the lockdown caused case numbers to drop, resulting in more relaxed 
containment measures over the summer and a resurgence in COVID-19 cases and deaths 
from September 2020 to January 2021 (second wave). The stringency of the containment 
measures was adapted accordingly (Supplementary Figure S1).  
In Switzerland, COVID-19 vaccine hesitancy has been rarely studied. Only recently, 
the first data regarding COVID-19 vaccine hesitancy in the general population have been 
published [11]. They show that the differences between the age groups are particularly 
striking. There are comparatively many people under 35 who are unwilling to be vac-
cinated, and whose confidence in vaccination, the responsible authorities, and the phar-
maceutical companies is lower than in all other age groups. Interestingly, while the 
youngest age group of 15-24 year olds shows equally high vaccine hesitancy, it is not ac-
companied by a particular skepticism towards the vaccination and its context. The per-
ception of being less affected by COVID-19 and less at risk may be an explanation [11]. 
To date, little is known on Swiss students’ attitudes towards vaccination in general 
and specifically regarding COVID-19, nor about differences across faculties and profes-
sions. Understanding the factors related to COVID-19 vaccine hesitancy and willingness 
in university students is critical for evidence-based public health communication and ef-
forts to increase vaccination rates [12]. The HEalth in Students during the Corona pan-
demic (HES-C) study [13] provided the opportunity to investigate vaccine willingness, 
hesitancy, and predictors in this under-investigated age group.  
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2. Materials and Methods 
2.1. Survey Design and Study Design 
Study data stem from the HES-C study [13], which aims to (1) evaluate the health of 
students during the pandemic, (2) investigate changes in health behavior and associated 
factors, and (3) assess students’ perception of the pandemic and related measures and 
their impact on students’ lives. All enrolled students at the Zurich University of Applied 
Sciences (ZHAW) (N = 13,500) were invited to participate in eight consecutive surveys 
administered between April 2020 and January 2021 in an open-cohort design. Each survey 
lasted about 20–25 minutes and ran for a total period of seven working days. Participants’ 
informed consent was obtained before each survey. In the present study, we used cross-
sectional data from the sixth survey wave (N = 1478). Data collection of the sixth wave 
took place from January 21st to January 29th, 2021. The study was approved by both the 
local cantonal ethics committee (BASEC-Nr. Req-2020–00366) and the ZHAW data pro-
tection officer. 
2.2. Missing Data 
Of the 1478 students who participated in the study, i.e., started the survey, 1358 
(91.9%) completed the survey. Information on COVID-19 vaccination intention, our pri-
mary outcome, was provided by 1357 students and complete data for all variables used in 
the analyses was available for 1297 students. Missing values were most prevalent in the 
variable “trust in the Federal Council’s vaccination strategy” (2.3%, n = 31) and ranged 
from 0% to 0.7% for the remaining variables. Incomplete cases amounted to 4.4% of the 
data. Moreover, we used the Stata mvpatterns and misschk commands to cross-tabulate and 
plot all combinations of missing and non-missing values of variables used in the analyses. 
Using visual inspection, we detected no systematic patterns in the missing data. For the 
above reasons, we did not impute missing data [14] and included 1297 complete cases 
throughout all analyses. 
2.3. Measures 
2.3.1. Outcome: Vaccination Intention 
COVID-19 vaccination intention was measured with a single item, used in the Swiss 
national Corona Immunitas Study [15], with a 6-point Likert scale: “As soon as a COVID-
19 vaccine is available, do you think you will get vaccinated?” (1 = no, 2 = probably no, 3 
= undecided, 4 = yes, after others, 5 = probably yes, 6 = yes).  
2.3.2. Predictors 
The psychological antecedents of vaccination were measured using the validated 5C 
scale [16]. The 5C scale is a self-assessment questionnaire that measures 5 different psy-
chological dimensions of vaccine hesitancy, i.e., confidence in vaccines (confidence), com-
placency (perceived disease risk), constraints (perceived barriers to vaccination), calcula-
tion (information-seeking behavior), and collective responsibility (awareness of social 
benefits of vaccination). The questionnaire is comprised of 15 items to be rated on a 5-
point Likert scale (from “Strongly disagree” to “Strongly agree”). Scores on each sub-scale 
represent the mean scores of the scale’s respective items and range from 1 to 5, with higher 
values representing more agreement.  
Students were asked to indicate their degree of trust in the government’s vaccination 
strategy on a 4-point Likert scale, i.e., “Would you say that you have no trust, little trust, 
trust or complete trust in the Federal Council’s vaccination strategy?”. Responses were 
then dichotomized as 0 (i.e., no trust, little trust) and 1 (i.e., trust, complete trust). With 
respect to previous vaccination experience, students were asked whether they had ever 
been vaccinated against seasonal influenza (0 = no, 1 = yes) and for travel medical precau-
tions (0 = no, 1 = yes), e.g., yellow fever.  




Socio-demographic covariates included students’ age at the last birthday in complete 
years, gender (0 = women, 1 = men), and faculty (0 = all other faculties, 1 = department of 
health professions). Wellbeing-related covariates included students’ self-rated health and 
anxiety. With respect to self-rated health, participants were asked “In general, would you 
say that your health is very poor, poor, fair, good, very good?”. Due to the low frequency 
of students who indicated very poor or poor health, i.e., 5.7% (n = 66), we dichotomized 
students into those with very good or good health and those with fair, poor, or very poor 
health with the latter category being the reference category. Anxiety was measured with 
the General Anxiety Disorder Scale-7 (GAD-7) [17]. The GAD-7 is a self-assessment ques-
tionnaire that measures the level of perceived anxiety in the last two weeks. The question-
naire is comprised of 7 items to be rated on a 4-point Likert scale (from “not at all” to 
“nearly every day”). The resulting sum score ranges from 0 to 21, with lower values indi-
cating a lower level of anxiety, and is categorized into four severity levels of anxiety: min-
imal (0–4), mild (5–9), moderate (10–14), and severe (15–21). 
2.4. Statistical Analyses 
Descriptive statistics (i.e., frequencies, percent, median, interquartile range, mean, 
standard deviation) were applied to evaluate the characteristics of the samples. We used 
univariate Student’s t-tests for continuous variables and Chi-square-tests for categorical 
variables to assess univariate group differences. Ordinal logistic regression models, i.e., 
proportional odds models, were used to estimate adjusted vaccination intention. Adjust-
ment comprised age, gender, faculty, health status, generalized anxiety, trust in the Swiss 
Federal Council’s vaccination strategy, previous seasonal influenza vaccination, previous 
travel vaccination, and psychological vaccination antecedents (confidence, complacency, 
constraints, calculation, collective responsibility). We report odds ratios (OR) with corre-
sponding 95% confidence intervals (95% CI), predictive margins (average predicted prob-
ability), and average marginal effects for major predictors. For the ordinal logistic model, 
the underlying proportional odds assumptions were checked using Brant test [18] and 
met in all models. Statistical significance was established at p < 0.05. We used Stata Version 
15.1 (StataCorp, College Station, TX, USA) for statistical analyses. 
3. Results 
3.1. Participants’ Characteristics 
The analytic sample consists of 912 women (70.3%) and 385 men (29.7%) (Table 1). 
Overall, the median age of students was 24 years; the interquartile range (IQR) was 22–27 
years. The corresponding age for female and male students was 24 years (IQR: 22–27) and 
24 years (IQR: 23–27) with no substantial differences in age between gender (p = 0.622). 
The percentage of health profession students was 23.1%, which is considerably higher 
than their share in the total ZHAW student population (13.0%). More women than men 
were health profession students (p ≤ 0.001). Roughly, three quarters of the students re-
ported their health to be very good or good, and women assessed their subjective health 
slightly better than men did (p = 0.007). The prevalence of moderate to severe anxiety lev-
els was 33.5% with no substantial differences between female and male students (p = 
0.765).  
Table 1. Participant characteristics. 
Variable Statistics Women Men Total 
Gender n (%) 912 (70.3) 385 (29.7) 1297 (100.0) 
Age Md (IQR) 24 (22–27) 24 (23–27) 24 (22–27) 
Health professions student *** n (%) 279 (30.6) 21 (5.5) 300 (23.1) 
(Very) good health status ** n (%) 689 (75.6) 263 (68.3) 952 (73.4) 
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Anxiety level n (%)       
Minimal (0–4)  246 (27.0) 109 (28.3) 355 (27.4) 
Mild (5–9)  358 (39.3) 149 (38.7) 507 (39.1) 
Moderate (10–14)  211 (23.1) 81 (21.0) 292 (22.5) 
Severe (15–21)  97 (10.6) 46 (12.0) 143 (11.0) 
Trust in vaccination strategy ** n (%) 412 (45.2) 199 (51.7) 611 (47.1) 
Previous vaccinations        
Seasonal influenza vaccination  n (%) 193 (21.2) 72 (18.7) 265 (20.4) 
Travel vaccination * n (%) 449 (49.2) 156 (40.5) 605 (46.7) 
5C vaccination antecedents Mean (SD)       
Confidence **  3.88 (0.87) 4.04 (0.89) 3.93 (0.88) 
Complacency *  1.96 (0.71) 2.07 (0.82) 1.99 (0.75) 
Constraints  1.36 (0.60) 1.43 (0.71) 1.38 (0.64) 
Calculation ***  3.73 (0.90) 3.44 (1.05) 3.64 (0.96) 
Collective responsibility  4.04 (0.91) 3.94 (1.04) 4.01 (0.95) 
COVID-19 vaccination intention n (%)       
No  71 (7.8) 27 (7.0) 98 (7.6) 
Probably no  126 (13.8) 54 (14.0) 180 (13.9) 
Undecided  144 (15.8) 43 (11.2) 187 (14.4) 
Yes, after others  136 (14.9) 58 (15.1) 194 (15.0) 
Probably yes  226 (24.8) 87 (22.6) 313 (24.1) 
Yes  209 (22.9) 116 (30.1) 325 (25.1) 
n = number of observations; Md = median; IQR = interquartile range; SD = standard deviation; difference across gender: 
*** p < 0.001, ** p < 0.01, * p < 0.05. We used univariate Student’s t-tests for continuous variables and Chi-square-tests for 
categorical variables to assess univariate group differences. 
A quarter of the students indicated that they would get vaccinated against COVID-
19 (yes 25.1%), and 7.6% responded they would not get vaccinated. Two-thirds were not 
absolutely sure (probably yes 24.1%, probably no 13.9%), undecided (14.4%), or wished to 
wait for others to get vaccinated first (15.0%). Positive vaccination intention in women 
was slightly lower than in men (p = 0.065). Trust in the Swiss Federal Council’s vaccination 
strategy was held by 45.2% of women and 51.7% of men (p = 0.032). A fifth of female 
(21.2%) and male students (18.7%) had previously been vaccinated against seasonal influ-
enza at least once (p = 0.315), while about half of the students (49.2%, respectively 40.5%), 
reported having had a travel vaccination in the past (p = 0.004). With respect to the psy-
chological antecedents of vaccination [16], female as compared to male students expressed 
lower levels of confidence (p = 0.003), complacency (p = 0.010), and constraints (p = 0.064; 
borderline significant), and higher levels of calculation (p < 0.001) and collective responsi-
bility (p = 0.088; borderline significant). 
3.2. Factors Associated with COVID-19 Vaccination Intention 
Adjusting for all other covariates (Table 2, crude OR Supplementary Table S1), vac-
cination intention was higher in participants who expressed trust in the Swiss Federal 
Council’s vaccination strategy (OR = 2.40; 95% CI: 1.89–3.05). Similarly, vaccination inten-
tion was higher in students who reported having been vaccinated at least once against 
influenza (OR = 1.39; 95% CI: 1.06–1.83) or for travel medical precautions (OR = 1.29; 95% 
CI: 1.04–1.60). With respect to the 5C vaccination antecedents, students who expressed 
more confidence in vaccination were more likely to consider being vaccinated (OR = 2.52; 
95% CI: 2.09–3.03) while higher complacency, i.e., not perceiving disease as high risk, was 
associated with lower vaccination intention (OR = 0.79; 95% CI: 0.66–0.96). Engaging in 
extensive information seeking, captured by the calculation dimension, was associated 
with lower vaccination intention (OR = 0.79; 95% CI: 0.70–0.89). Students who were more 
prone to consider aspects pertaining to collective responsibility, i.e., willingness to protect 
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others, were more likely to consider being vaccinated (OR = 4.47; 95% CI: 3.69–5.40). The 
dimension constraints, e.g., perceived geographical or financial barriers, were positively 
associated with vaccination intention but were only borderline significant (OR = 1.18; 95% 
CI: 0.99–1.41).  
Table 2. COVID-19 vaccination intention—adjusted ordinal logistic regression model. 
Variable OR p 95% CI 
Gender (ref = women)    
Men 1.30 0.038 1.01–1.66 
Age (years) 1.03 0.001 1.01–1.05 
Health professions student (ref = no)    
Yes 0.94 0.621 0.72–1.22 
Health status (ref = poor-fair health)    
Very good/good health 0.74 0.026 0.57–0.96 
Generalized anxiety (ref = minimal (0–4))    
Mild (5-9) 0.94 0.663 0.73–1.23 
Moderate (10-14) 0.97 0.854 0.71–1.33 
Severe (15-21) 0.73 0.136 0.48–1.11 
Trust in vaccination strategy (ref = no)    
Yes 2.40 0.000 1.89–3.05 
Seasonal influenza vaccination (ref = no)    
Yes 1.39 0.019 1.06–1.83 
Travel vaccination (ref = no)    
Yes 1.29 0.020 1.04–1.60 
5C vaccination antecedents    
Confidence 2.52 0.000 2.09–3.03 
Complacency 0.79 0.018 0.66–0.96 
Constraints 1.18 0.072 0.99–1.41 
Calculation 0.79 0.000 0.70–0.89 
Collective responsibility 4.47 0.000 3.69–5.40 
Cut points    
#1 4.13  2.89–5.36 
#2 6.44  5.17–7.71 
#3 7.96  6.66–9.26 
#4 9.23  7.91–10.55 
#5 11.12  9.77–12.48 
Number of observations 1297   
Pseudo R-squared 0.29   
Likelihood ratio Chi2 (15) 1308   
p > Chi2 0.000   
ref = reference category; OR = odds ratio; p = probability; 95% CI = 95% confidence interval; cut points mark boundaries 
on the latent variable y * where the outcome changes, i.e., the probability of an observed outcome for a given x is the area 
under the curve between a pair of cut points. 
With respect to student characteristics, included in the model to control for potential 
confounding, some of the differences seen in univariate analyses remain significant. Male 
students (OR = 1.30; 95% CI: 1.01–1.66) and older students (OR = 1.03; 95% CI: 1.01–1.05) 
were more likely to consider COVID-19 vaccination, and very good or good health was 
negatively associated with vaccination intention (OR = 0.74; 95% CI: 0.57–0.96). Health 
profession students compared to all other students were no longer significantly different 
in their vaccination intention. Additionally, different levels of anxiety were not associated 
with vaccination intention.  
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The predictive margins for each of the vaccination intention categories (no; probably 
no; undecided; yes, after others; probably yes; yes) were 0.076 (95% CI: 0.065–0.086), 0.135 
(95% CI: 0.119–0.151), 0.144 (95% CI: 0.0.127–0.162), 0.151 (95% CI: 0.132–0.169), 0.243 (95% 
CI: 0.221–0.264), and 0.251 (95% CI: 0.232–0.270), respectively. These average predicted 
probabilities lie near the empirical distribution of vaccination intention presented in Table 
1.  
Figure 1 depicts predicted probabilities of each vaccination intention category over 
the range of the different 5C antecedents. Vaccination intention trajectories were most 
pronounced for the confidence and collective dimensions (Figure 1, panels A and E). 
Based on the ordinal logistic regression model, the vaccination intention categories “yes” 
or “probably yes” were more likely in students who expressed strong confidence in vac-
cination (strongly agree), while students who had little confidence in vaccination (strongly 
disagree) were more probable to report the vaccination intention categories “no”, “prob-
ably no”, or “undecided”. Along the scale, the probability of the latter vaccination inten-
tion categories coherently decreased or increased, respectively. A similar pattern can be 
observed for the collective dimension where after adjustment the “yes” or “probably yes” 
vaccination intention category was most likely for students who strongly agreed that vac-
cination is a collective endeavor while those who strongly disagreed were more likely to 
be in the “no” and “probably no” categories. For the remaining three dimensions, the pat-
terns were less coherent. While students who strongly disagreed on the complacency scale 
were most likely to be to belong to the “yes” or “probably yes” group, there was no pro-
nounced decreasing trend over the complacency scale (Figure 1, panel B). Moreover, stu-
dents who strongly agreed on the complacency scale were still more likely to report “prob-
ably yes” or equally likely “yes”, “yes, after others”, “undecided”, or “probably no” re-
garding their vaccination intention. A similar pattern can be observed for the calculation 
and constraints dimension. These findings are in line with the fact that the average mar-
ginal effects of confidence and collective responsibility on the probability, i.e., up to 0.18, 
far exceeded those of the remaining 5C dimensions where effects on probability were in a 
negligible range of ±0.02. With respect to effects on probability, trust in the Federal Coun-
cil’s vaccination strategy and influenza vaccination too contributed substantially, espe-
cially regarding the “yes” vaccination intention category (Figure 2). To a lesser degree, 
this is also the case for travel precaution vaccination.  




Figure 1. Predictive margins of vaccination intention categories by 5C antecedents. Legend: Aver-
age predicted probability of each vaccination intention category: confidence (panel A), compla-
cency (panel B), calculation (panel C), constraints (panel D), and collective (panel E). Whiskers 
show the 95% confidence interval of the point estimates.  
 
Figure 2. Average marginal effect of trust in the government’s vaccination strategy, seasonal influ-
enza vaccination, and travel vaccination. Legend: Difference in probabilities by vaccination inten-
tion category for participants who trust the vaccination strategy (panel A), who had an influenza 
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vaccination (panel B), who had a travel precaution vaccination. Whiskers show the 95% confidence 
interval of the point estimates.  
4. Discussion 
In our sample of Swiss students, a considerable proportion of young people were 
unsure or undecided regarding their vaccination intention. Only a third had made up 
their mind in January 2020. Overall, half responded they would or probably would get 
vaccinated against COVID-19. This rate is somewhat lower compared to rates reported 
for other countries [12,19]. Several demographic characteristics, vaccination history, trust 
in the government’s vaccination strategy, and psychological vaccination antecedents were 
positively associated with COVID-19 vaccination intention. 
An important finding of this study is that four of five specific dimensions of the gen-
eralized measure of psychological vaccination antecedents, the 5C scale [16], were signif-
icantly associated with COVID-19 vaccination intention among Swiss students. This is the 
first study, to our knowledge, using the 5C scale in students. Higher scores on confidence 
and collective responsibility were associated with a positive COVID-19 vaccination inten-
tion, while lower scores on complacency and calculation were associated with a negative 
intention. This is consistent with similar findings by Kwok et al. [20] among health care 
workers in Hongkong and Dorman et al. [21] in a large convenience sample in the US, 
where the strongest correlations and effects were found for confidence in the safety of the 
vaccine and concern about protecting others through vaccination (collective responsibil-
ity) [21]. The dimension constraints was not significantly associated with vaccination in-
tention. 
The 5C antecedent confidence relates to trust in the safety and effectiveness of the 
COVID-19 vaccine as well the belief that public authorities decide in the best interest of 
the community. While trust in public authorities is included in the measure, apparently it 
did not capture all aspects of trust, as the predictor “trust in the government’s vaccination 
strategy” proved to be an independent factor and was significantly and positively associ-
ated with vaccination intention. Trust in the government is generally high in Switzerland 
[22], but with regard to COVID-19 it decreased over the course of the pandemic [23]. For 
example, confidence in the government’s competence to cope with the COVID-19 pan-
demic was almost double in the ZHAW student body in the first survey in April 2020, 
with 87% voicing trust in the federal council and 97% in the federal office of public health, 
as compared to the current confidence in the government’s vaccination strategy [24]. 
Strengthening confidence and trust in public authorities seems to be an essential factor to 
increase COVID-19 vaccination rates, as confirmed by other studies [7,25]. For example, 
Murphy et al. [7] observed that COVID-19 vaccine-hesitant or -resistant adults in Ireland 
and the UK distrust experts and authority figures (i.e., scientists, health professionals, the 
state) more and present more conspiratorial and paranoid beliefs reflecting a lack of trust 
in the intentions of others. We further investigated the vaccination history, under the as-
sumption that previous vaccination decisions are likely to predict future decisions and are 
closely related to the dimension of confidence. Previous vaccinations may indicate a gen-
eral trust in vaccines and an understanding of the health benefit of vaccinations. Our re-
sults yield that, in fact, students who reported a previous seasonal influenza vaccination 
or travel vaccination had an increased odds of positive COVID-19 vaccination intention. 
Schwarzinger et al. [26], investigating French 16–64 year-olds, also showed that both out-
right vaccine refusal and vaccine hesitancy were significantly associated with poor com-
pliance with recommended vaccinations in the past, and Ruiz and Bell [27] observed that 
influenza vaccine uptake was a significant predictor of vaccination intent in the general 
American public. 
Furthermore, collective responsibility, defined as the willingness to protect others by 
the means of one’s own vaccination, was observed to be an important factor in COVID-19 
vaccination intention in this study. While this result is also found in other populations, 
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such as health professionals [20,28] and older populations [29,30], it may have been un-
derestimated in younger individuals. In our study, students who rated high on collective 
responsibility showed five-times higher odds of getting vaccinated than students who 
rated lower. To tackle COVID-19 vaccine hesitancy, increasing collective responsibility in 
young adults seems to be critical. 
Complacency, i.e., a low risk perception, is a significant predictor of COVID-19 vac-
cination intention. This is consistent with Schwarzinger et al. [26] as well as Ruiz and Bell 
[27] who highlighted that vaccine refusal was associated with a lower perceived severity 
of COVID-19. In particular, younger people are more likely to be complacent about the 
risk of COVID-19 than older people [24] because they are less likely to be hospitalized or 
to die from COVID-19 [31]. Indeed, initially, the communication about COVID-19 nur-
tured the idea that young people had little to fear [32]. In our study, we find the expected 
direction of effect; however, it is overall a small effect. Possibly, with increasing 
knowledge on the short- and long-term health risks, such as long COVID [33,34], and the 
personal inconveniences resulting from a suspected or true infection, such as isolation or 
quarantine, the perception of risk has changed. 
The dimension calculation, referring to the correlation between individuals’ engage-
ment in extensive information-seeking behavior and decision making, had a significant 
influence on COVID-19 vaccination intention, but again only a small overall effect. The 
underlying assumption is that extensive information seeking leads to a higher exposure 
to vaccine-critical individuals, since critical voices are disproportionally more prominent 
in the internet [16], and media controversies and vaccine-critical sources have a negative 
impact on vaccine willingness [35–41]. The information source “social media” has been 
found to be associated with COVID-19 conspiracy beliefs and with higher vaccine hesi-
tancy [42]. While international studies indicate that students often rely on social media 
information [40,43], we do not observe this behavior in our student body. A previous pub-
lished paper found that ZHAW students’ first and second choice of information source in 
relation to COVID-19 were public media and public health institutions and social media 
was only the third most frequent information source [24]. This may partially explain the 
small effect of calculation, next to the fact that students most likely have a higher data 
literacy than the general population. 
While our main predictors were the psychological antecedents, trust in vaccination 
strategy, and previous vaccination history, it is worthwhile to report the findings on socio-
demographic covariates and health status. Most COVID-19 vaccination literature reports 
a gender difference in vaccine hesitancy [7,25–27,44]; a recent rapid review, however, indi-
cated a large inconsistency of results [45]. In our study, male participants were more will-
ing to be vaccinated than females, independent of psychological antecedents, vaccination 
history or trust in vaccination strategy. Furthermore, higher age is known to be associated 
with lower vaccine hesitancy or refusal, and this association is supported by recent 
COVID-19 publications [11,25,27]. The general explanation for this age effect is an age-
dependent perception of the individual risk. Albeit the small age range covered by our 
study participants, we observed a small but significant positive age effect. However, the 
student population does not fall into the at-risk age group; therefore, we must assume 
other factors underlying the age effect. One explanation might be that older students tend 
to have older parents for whose health they are concerned. In fact, in an earlier analysis 
[24], we identified that the concern expressed for parents was higher than concern for 
students’ own health. In agreement with most literature, we found students with better 
self-reported health status to have a lower intention to get vaccinated. For example, 
Schwarzinger et al. [26] indicated that absence of chronic conditions is associated with 
vaccine hesitancy. Ruiz and Bell [27] observed that intent to vaccinate was highest for 
people with pre-existing medical conditions. However, the literature is inconsistent, as 
Kelly et al. [44] reported that individuals with underlying medical conditions or morbid 
obesity were no more willing to get vaccinated against COVID-19 than their lower risk 
counterparts.  
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Our study investigated vaccine hesitancy prior to vaccination being available for this 
age group; however, the vaccines themselves were approved for the respective age range 
and it was only a matter of time that COVID-19 vaccines would become available. The 
survey was held in January 2021, in a phase of highly stringent containment measures and 
near the end of the second wave. Therefore, the COVID-19 pandemic was very present 
and heavily discussed in the media. Students experienced themselves many containment 
measures, from online teaching, masks in public places and transport, or restrictions in 
movement and meeting family and friends. One might have expected a high understand-
ing of the importance of vaccinations over the course of the COVID-19 pandemic at the 
given time. Nevertheless, the hypothetical wording may have influenced the response, 
and in this early stage of vaccination campaigns students may not have made up their 
mind. We captured this indecisiveness with the answer option “probably yes or no”. The 
ordinal logistic regression analyses allowed us take various steps of indecisiveness into 
account, which would have been lost in dichotomizing the variable responses.  
A critical point is the representativity of our findings. For one, more women partici-
pated in the survey, which might have led to an overestimation of vaccine hesitancy in 
the crude data. However, the main analysis, the ordinal logistic regression, adjusts for 
gender. Secondly, the sample consisted of students from a German-speaking Swiss uni-
versity of applied sciences and was representative of the student body. While we are con-
fident that the study can be generalized to other German-speaking universities, it should 
not be generalized to French- or Italian-speaking language regions in Switzerland, espe-
cially since vaccine hesitancy seems to be higher in Italian or French speakers [11]. Further, 
the sample is not representative for young adults in general. While Swiss universities of 
applied science attract students from different educational paths and backgrounds, they 
belong to the more highly educated population. Several studies reported that individuals 
with a high education level were more likely to be vaccinated against COVID-19 than 
individuals with a low education level [10,45–50].  
5. Conclusions 
Addressing psychological antecedents of vaccination intention in communications 
and interventions may result in more targeted and successful campaigns. Our results pro-
vide valuable evidence for future public health policy and vaccination campaigns. For 
one, the data show that students are highly susceptible to the collective dimension of vac-
cination. Second, addressing previous vaccination choices such as travel or influenza vac-
cinations may be a good angle to address hesitancy. Third, low risk perception predicts 
low vaccination intention and, thus, needs to be addressed in health communications, and 
further, strengthening and reassuring the confidence in the vaccination strategy and vac-
cination itself must be a central aim in vaccination campaigns. Universities themselves 
provide a good setting to reach students and to launch information campaigns. Addition-
ally, lastly, the repeatedly observed difference by gender needs further investigations to 
better target the more hesitant female gender. 
Supplementary Materials: The following are available online at www.mdpi.com/1660-
4601/18/17/9210/s1, Figure S1: Epidemiological data and KOF Stringency Index over the duration of 
the HES-C study, Table S1: COVID-19 vaccination intention—unadjusted ordinal logistic regression 
model.  
Author Contributions: Conceptualization, J.D., T.V., and A.Z.; methodology, J.D., T.V., and A.Z.; 
formal analysis, T.V. and A.W.; investigation, J.D., T.V., and A.Z.; data curation, T.V.; writing—
original draft preparation, J.D. and A.W., writing—review and editing, T.V. and A.Z.; supervision, 
J.D. and T.V.; project administration, J.D.; funding acquisition (internal funding). All authors have 
read and agreed to the published version of the manuscript. 
Funding: This research received no external funding. 
Int. J. Environ. Res. Public Health 2021, 18, 9210 12 of 14 
 
 
Institutional Review Board Statement: The study was conducted according to the guidelines of the 
Declaration of Helsinki and approved by both the local cantonal ethics committee (BASEC Nr. Req-
2020-00326) and the ZHAW data protection officer. 
Informed Consent Statement: Informed consent was obtained from all subjects involved in the 
study prior to filling in the online survey. 
Data Availability Statement: Data have not been made publicly available so far since the HES-C 
data collection was terminated only in June 2021. The study data presented in this study are availa-
ble on request from the corresponding author. 
Acknowledgments: We would like to thank the ZHAW students who participated in the study for 
their engagement and time. The HES-C research group, consisting of Julia Dratva (PI), Thomas 
Volken (Co-PI), Annina Zysset, Agnes von Wyl, Marion Huber, and Simone Amendola, has dedi-
cated itself to studying young adult health during the pandemic. 
Conflicts of Interest: The authors declare no conflict of interest.  
References 
1. Fischer, A. SARS-CoV-2 Vaccines, Where Do We Stand? Comptes Rendus Biol. 2021, 344, 43–55, doi:10.5802/crbiol.35. 
2. Abdulla, Z.A.; Al-Bashir, S.M.; Al-Salih, N.S.; Aldamen, A.A.; Abdulazeez, M.Z. A Summary of the SARS-CoV-2 Vaccines and 
Technologies Available or under Development. Pathogens 2021, 10, 788, doi:10.3390/pathogens10070788. 
3. Fadda, M.; Albanese, E.; Suggs, L.S. When a COVID-19 Vaccine Is Ready, Will We All Be Ready for It? Int. J. Public Health 2020, 
65, 711–712, doi:10.1007/s00038-020-01404-4. 
4. MacDonald, N.E. Vaccine Hesitancy: Definition, Scope and Determinants. Vaccine 2015, 33, 4161–4164, doi:10.1016/j.vac-
cine.2015.04.036. 
5. Lane, S.; MacDonald, N.E.; Marti, M.; Dumolard, L. Vaccine Hesitancy around the Globe: Analysis of Three Years of 
WHO/UNICEF Joint Reporting Form Data-2015–2017. Vaccine 2018, 36, 3861–3867, doi:10.1016/j.vaccine.2018.03.063. 
6. Wiysonge, C.S.; Ndwandwe, D.; Ryan, J.; Jaca, A.; Batouré, O.; Anya, B.-P.M.; Cooper, S. Vaccine Hesitancy in the Era of COVID-
19: Could Lessons from the Past Help in Divining the Future? Hum. Vaccines Immunother. 2021, 
doi:10.1080/21645515.2021.1893062. 
7. Murphy, J.; Vallières, F.; Bentall, R.P.; Shevlin, M.; McBride, O.; Hartman, T.K.; McKay, R.; Bennett, K.; Mason, L.; Gibson-Miller, 
J.; et al. Psychological Characteristics Associated with COVID-19 Vaccine Hesitancy and Resistance in Ireland and the United 
Kingdom. Nat. Commun. 2021, 12, 29, doi:10.1038/s41467-020-20226-9. 
8. Sharma, M.; Davis, R.E.; Wilkerson, A.H. COVID-19 Vaccine Acceptance among College Students: A Theory-Based Analysis. 
Int. J. Environ. Res. Public Health 2021, 18, 4617, doi:10.3390/ijerph18094617. 
9. Lu, H.; Weintz, C.; Pace, J.; Indana, D.; Linka, K.; Kuhl, E. Are College Campuses Superspreaders? A Data-Driven Modeling 
Study. Comput. Methods Biomech. Biomed. Eng. 2021, doi:10.1080/10255842.2020.1869221. 
10. Sallam, M.; Dababseh, D.; Eid, H.; Hasan, H.; Taim, D.; Al-Mahzoum, K.; Al-Haidar, A.; Yaseen, A.; Ababneh, N.A.; Assaf, A.; 
et al. Low COVID-19 Vaccine Acceptance Is Correlated with Conspiracy Beliefs among University Students in Jordan. Int. J. 
Environ. Res. Public Health 2021, 18, 2407, doi:10.3390/ijerph18052407. 
11. Hermann, M. Special Report on Covid-19 Vaccination (Spezialauswertung COVID-19-Impfung: Informationsstand, Einstellungen Und 
Verhalten; Forschungsstelle sotomo: Bern, Switzerland, 2021. 
12. Afifi, T.O.; Salmon, S.; Taillieu, T.; Stewart-Tufescu, A.; Fortier, J.; Driedger, S.M. Older Adolescents and Young Adults 
Willingness to Receive the COVID-19 Vaccine: Implications for Informing Public Health Strategies. Vaccine 2021, 39, 3473–3479, 
doi:10.1016/j.vaccine.2021.05.026. 
13. Studie zur Gesundheit von Studierenden in Zeiten der Corona-Pandemie. Available online: 
https://www.zhaw.ch/de/gesundheit/forschung/gesundheitswissenschaften/projekte/studierendengesundheit/ (accessed on 19 
August 2021). 
14. Jakobsen, J.C.; Gluud, C.; Wetterslev, J.; Winkel, P. When and How Should Multiple Imputation Be Used for Handling Missing 
Data in Randomised Clinical Trials—Practical Guide with Flowcharts. BMC Med. Res. Methodol. 2017, 17, 162, 
doi:10.1186/s12874-017-0442-1. 
15. Corona Immunitas. Available online: https://www.corona-immunitas.ch/ (accessed on 21 July 2021). 
16. Betsch, C.; Schmid, P.; Heinemeier, D.; Korn, L.; Holtmann, C.; Böhm, R. Beyond Confidence: Development of a Measure 
Assessing the 5C Psychological Antecedents of Vaccination. PLoS ONE 2018, 13, e0208601, doi:10.1371/journal.pone.0208601. 
17. Spitzer, R.L.; Kroenke, K.; Williams, J.B.W.; Löwe, B. A Brief Measure for Assessing Generalized Anxiety Disorder: The GAD-
7. Arch. Intern. Med. 2006, 166, 1092, doi:10.1001/archinte.166.10.1092. 
18. Brant, R. Assessing Proportionality in the Proportional Odds Model for Ordinal Logistic Regression. Biometrics 1990, 46, 1171–
1178, doi:10.2307/2532457. 
19. Brandt, E.J.; Rosenberg, J.; Waselewski, M.E.; Amaro, X.; Wasag, J.; Chang, T. National Study of Youth Opinions on Vaccination 
for COVID-19 in the U.S. J. Adolesc. Health 2021, 68, 869–872, doi:10.1016/j.jadohealth.2021.02.013. 
Int. J. Environ. Res. Public Health 2021, 18, 9210 13 of 14 
 
 
20. Kwok, K.O.; Li, K.-K.; WEI, W.I.; Tang, A.; Wong, S.Y.S.; Lee, S.S. Influenza Vaccine Uptake, COVID-19 Vaccination Intention 
and Vaccine Hesitancy among Nurses: A Survey. Int. J. Nurs. Stud. 2021, 114, 103854, doi:10.1016/j.ijnurstu.2020.103854. 
21. Dorman, C.; Perera, A.; Condon, C.; Chau, C.; Qian, J.; Kalk, K.; DiazDeleon, D. Factors Associated with Willingness to Be 
Vaccinated Against COVID-19 in a Large Convenience Sample. J. Commun. Health 2021, doi:10.1007/s10900-021-00987-0. 
22. OECD. Government at a Glance 2017; Government at a Glance; OECD Publishing: Paris, France, 2017; ISBN 978-92-64-26872-2. 
23. Hermann, M. COVID-19-Präventionsmassnahmen: Informationsstand, Einstellungen Und Verhalten—Bericht Zur Wirkungsmessung 
von Ende Oktober 2020 Im Auftrag Des Bundesamts Für Gesundheit BAG; Forschungsstelle Sotomo: Bern, Switzerland, 2020. 
24. Zysset, A.E.; Schlatter, N.; von Wyl, A.; Huber, M.; Volken, T.; Dratva, J. Students’ Experience and Adherence to Containment 
Measures during COVID-19 in Switzerland. Health Promot. Int. 2021, doi:10.1093/heapro/daab019. 
25. Thaker, J. The Persistence of Vaccine Hesitancy: COVID-19 Vaccination Intention in New Zealand. J. Health Commun. 2021, 26, 
104–111, doi:10.1080/10810730.2021.1899346. 
26. Schwarzinger, M.; Watson, V.; Arwidson, P.; Alla, F.; Luchini, S. COVID-19 Vaccine Hesitancy in a Representative Working-
Age Population in France: A Survey Experiment Based on Vaccine Characteristics. Lancet Public Health 2021, 6, e210–e221, 
doi:10.1016/S2468-2667(21)00012-8. 
27. Ruiz, J.B.; Bell, R.A. Predictors of Intention to Vaccinate against COVID-19: Results of a Nationwide Survey. Vaccine 2021, 39, 
1080–1086, doi:10.1016/j.vaccine.2021.01.010. 
28. Al-Sanafi, M.; Sallam, M. Psychological Determinants of COVID-19 Vaccine Acceptance among Healthcare Workers in Kuwait: 
A Cross-Sectional Study Using the 5C and Vaccine Conspiracy Beliefs Scales. Vaccines 2021, 9, 701, doi:10.3390/vaccines9070701. 
29. Kwok, K.O.; Li, K.K.; Tang, A.; Tsoi, M.T.F.; Chan, E.Y.Y.; Tang, J.W.T.; Wong, A.; Wei, W.I.; Wong, S.Y.S. Psychobehavioral 
Responses and Likelihood of Receiving COVID-19 Vaccines during the Pandemic, Hong Kong. Emerg. Infect. Dis. 2021, 27, 1802–
1810, doi:10.3201/eid2707.210054. 
30. Sherman, S.M.; Smith, L.E.; Sim, J.; Amlôt, R.; Cutts, M.; Dasch, H.; Rubin, G.J.; Sevdalis, N. COVID-19 Vaccination Intention in 
the UK: Results from the COVID-19 Vaccination Acceptability Study (CoVAccS), a Nationally Representative Cross-Sectional 
Survey. Hum. Vaccines Immunother. 2021, 17, 1612–1621, doi:10.1080/21645515.2020.1846397. 
31. Bhopal, S.S.; Bagaria, J.; Olabi, B.; Bhopal, R. Children and Young People Remain at Low Risk of COVID-19 Mortality. Lancet 
Child Adolesc. Health 2021, 5, e12–e13, doi:10.1016/S2352-4642(21)00066-3. 
32. Abbott, A.; Askelson, N.; Scherer, A.M.; Afifi, R.A. Critical Reflections on COVID-19 Communication Efforts Targeting 
Adolescents and Young Adults. J. Adolesc. Health 2020, 67, 159–160, doi:10.1016/j.jadohealth.2020.05.013. 
33. Gebhard, C.E.; Sütsch, C.; Bengs, S.; Deforth, M.; Buehler, K.P.; Hamouda, N.; Meisel, A.; Schuepbach, R.A.; Zinkernagel, A.S.; 
Brugger, S.D.; et al. Sex- and Gender-Specific Risk Factors of Post-COVID-19 Syndrome: A Population-Based Cohort Study in 
Switzerland. medRxiv 2021, 2021.06.30.21259757, doi:10.1101/2021.06.30.21259757. 
34. Menges, D.; Ballouz, T.; Anagnostopoulos, A.; Aschmann, H.E.; Domenghino, A.; Fehr, J.S.; Puhan, M.A. Burden of Post-
COVID-19 Syndrome and Implications for Healthcare Service Planning: A Population-Based Cohort Study. PLoS ONE 2021, 16, 
e0254523, doi:10.1371/journal.pone.0254523. 
35. Gangarosa, E.J.; Galazka, A.M.; Wolfe, C.R.; Phillips, L.M.; Gangarosa, R.E.; Miller, E.; Chen, R.T. Impact of Anti-Vaccine 
Movements on Pertussis Control: The Untold Story. Lancet 1998, 351, 356–361, doi:10.1016/s0140-6736(97)04334-1. 
36. Smith, A.; Yarwood, J.; Salisbury, D.M. Tracking Mothers’ Attitudes to MMR Immunisation 1996–2006. Vaccine 2007, 25, 3996–
4002, doi:10.1016/j.vaccine.2007.02.071. 
37. Mason, B.W.; Donnelly, P.D. Impact of a Local Newspaper Campaign on the Uptake of the Measles Mumps and Rubella Vaccine. 
J. Epidemiol. Commun. Health 2000, 54, 473–474, doi:10.1136/jech.54.6.473. 
38. Suppli, C.H.; Hansen, N.D.; Rasmussen, M.; Valentiner-Branth, P.; Krause, T.G.; Mølbak, K. Decline in HPV-Vaccination Uptake 
in Denmark—The Association between HPV-Related Media Coverage and HPV-Vaccination. BMC Public Health 2018, 18, 1360, 
doi:10.1186/s12889-018-6268-x. 
39. Hansen, N.D.; Mølbak, K.; Cox, I.J.; Lioma, C. Relationship Between Media Coverage and Measles-Mumps-Rubella (MMR) 
Vaccination Uptake in Denmark: Retrospective Study. JMIR Public Health Surveill 2019, 5, e9544, doi:10.2196/publichealth.9544. 
40. Jain, J.; Saurabh, S.; Kumar, P.; Verma, M.K.; Goel, A.D.; Gupta, M.K.; Bhardwaj, P.; Raghav, P.R. COVID-19 Vaccine Hesitancy 
among Medical Students in India. Epidemiol. Infect. 2021, 149, e132, doi:10.1017/S0950268821001205. 
41. Dubé, E.; Laberge, C.; Guay, M.; Bramadat, P.; Roy, R.; Bettinger, J.A. Vaccine Hesitancy. Hum. Vaccines Immunother. 2013, 9, 
1763–1773, doi:10.4161/hv.24657. 
42. Romer, D.; Jamieson, K.H. Patterns of Media Use, Strength of Belief in COVID-19 Conspiracy Theories, and the Prevention of 
COVID-19 From March to July 2020 in the United States: Survey Study. J. Med. Internet Res. 2021, 23, e25215, doi:10.2196/25215. 
43. Kanyike, A.M.; Olum, R.; Kajjimu, J.; Ojilong, D.; Akech, G.M.; Nassozi, D.R.; Agira, D.; Wamala, N.K.; Asiimwe, A.; Matovu, 
D.; et al. Acceptance of the Coronavirus Disease-2019 Vaccine among Medical Students in Uganda. Trop. Med. Health 2021, 49, 
37, doi:10.1186/s41182-021-00331-1. 
44. Kelly, B.J.; Southwell, B.G.; McCormack, L.A.; Bann, C.M.; MacDonald, P.D.M.; Frasier, A.M.; Bevc, C.A.; Brewer, N.T.; Squiers, 
L.B. Predictors of Willingness to Get a COVID-19 Vaccine in the U.S. BMC Infect. Dis. 2021, 21, 338, doi:10.1186/s12879-021-
06023-9. 
45. Lin, C.; Tu, P.; Beitsch, L.M. Confidence and Receptivity for COVID-19 Vaccines: A Rapid Systematic Review. Vaccines 2020, 9, 
16, doi:10.3390/vaccines9010016. 
Int. J. Environ. Res. Public Health 2021, 18, 9210 14 of 14 
 
 
46. Soares, P.; Rocha, J.V.; Moniz, M.; Gama, A.; Laires, P.A.; Pedro, A.R.; Dias, S.; Leite, A.; Nunes, C. Factors Associated with 
COVID-19 Vaccine Hesitancy. Vaccines 2021, 9, 300, doi:10.3390/vaccines9030300. 
47. Reiter, P.L.; Pennell, M.L.; Katz, M.L. Acceptability of a COVID-19 Vaccine among Adults in the United States: How Many 
People Would Get Vaccinated? Vaccine 2020, 38, 6500–6507, doi:10.1016/j.vaccine.2020.08.043. 
48. Fisher, K.A.; Bloomstone, S.J.; Walder, J.; Crawford, S.; Fouayzi, H.; Mazor, K.M. Attitudes Toward a Potential SARS-CoV-2 
Vaccine: A Survey of U.S. Adults. Ann. Intern. Med. 2020, 173, 964–973, doi:10.7326/M20-3569. 
49. Mercadante, A.R.; Law, A.V. Will They, or Won’t They? Examining Patients’ Vaccine Intention for Flu and COVID-19 Using the 
Health Belief Model. Res. Soc. Adm. Pharm. 2021, 17, 1596–1605, doi:10.1016/j.sapharm.2020.12.012. 
50. Lazarus, J.V.; Wyka, K.; Rauh, L.; Rabin, K.; Ratzan, S.; Gostin, L.O.; Larson, H.J.; El-Mohandes, A. Hesitant or Not? The 
Association of Age, Gender, and Education with Potential Acceptance of a COVID-19 Vaccine: A Country-Level Analysis. J. 
Health Commun. 2020, 25, 799–807, doi:10.1080/10810730.2020.1868630. 
 
